Middle East and Africa Hypophosphatasia Treatment Market

Description

List of Tables

Middle East and Africa hypophosphatasia treatment market is expected to reach USD 24.44 million by 2031, from USD 20.07 million in 2023 growing at the CAGR of 2.9% in the forecast period of 2024 to 2031.

Market Segmentation

Middle East and Africa Hypophosphatasia Treatment Market, By Types (Odontohypophosphatasia, Pseudohypophosphatasia, and Others), Therapy Type (Enzyme Replacement Therapy and Supportive Therapy), Route of Administration (Injectable and Oral), End User (Hospitals, Speciality Clinics, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Country (South Africa, U.A.E., Saudi Arabia, Egypt, Israel, and rest of Middle East and Africa) - Industry Trends and Forecast to 2031

Overview of Middle East and Africa Hypophosphatasia Treatment Market Dynamics

Drivers
Increasing incidence rate for hypophosphatasia
Continuous increase in clinical trials and pipeline products
Favorable reimbursement policies
Restraints
High cost of treatment
Complex treatment regimen
Opportunities
Increasing adoption of various types of advanced therapy
Initiatives by the government to create awareness
Challenges
Impact of discontinuation of drug treatment and related adverse effect
Genetic variability and disease complexity

Market Players

The key market players for Middle East and Africa hypophosphatasia treatment market are listed below:

AstraZeneca
Pfizer Inc.
Abbott
Novartis AG
AM-Pharma B.V.
Be Biopharma
PuREC
Rallybio
Rampart Bioscience, Inc.
Roivant Sciences Ltd.

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.10 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
4.3 STRATEGIC DECISIONS
4.4 PATENT ANALYSIS
4.5 PRODUCT SALES BY YEAR

5 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA (HPP) TREATMENT MARKET: REGULATIONS

5.1 U.S. REGULATORY SCENARIO FOR HYPOPHOSPHATASIA (HPP) TREATMENT
5.2 EUROPE REGULATORY SCENARIO FOR HYPOPHOSPHATASIA (HPP) TREATMENT
5.3 INDIA
5.4 MIDDLE EAST AND AFRICA

6 MARKET OVERVIEW

6.1 DRIVERS
- 6.1.1 INCREASING INCIDENCE RATE FOR HYPOPHOSPHATASIA
- 6.1.2 CONTINUOUS INCREASE IN CLINICAL TRIALS AND PIPELINE PRODUCTS
- 6.1.3 FAVOURABLE REIMBURSEMENT POLICIES
6.2 RESTRAINTS
- 6.2.1 HIGH COST OF TREATMENT
- 6.2.2 COMPLEX TREATMENT REGIMEN
6.3 OPPORTUNITIES
- 6.3.1 INCREASING ADOPTION OF VARIOUS TYPES OF ADVANCED THERAPY
- 6.3.2 INITIATIVES BY THE GOVERNMENT TO CREATE AWARENESS
6.4 CHALLENGES
- 6.4.1 IMPACT OF DISCONTINUATION OF DRUG TREATMENT AND RELATED ADVERSE EFFECT
- 6.4.2 GENETIC VARIABILITY AND DISEASE COMPLEXITY

7 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES

7.1 OVERVIEW
7.2 ODONTOHYPOPHOSPHATASIA
7.3 PSEUDOHYPOPHOSPHATASIA
7.4 OTHERS

8 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE

8.1 OVERVIEW
8.2 ENZYME REPLACEMENT THERAPY
8.3 SUPPORTIVE THERAPY

9 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

9.1 OVERVIEW
9.2 INJECTABLE
9.3 ORAL

10 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW
10.2 HOSPITAL PHARMACY
10.3 RETAIL PHARMACY
10.4 ONLINE PHARMACY

11 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER

11.1 OVERVIEW
11.2 HOSPITALS
11.3 SPECIALTY CLINICS
11.4 OTHERS

12 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION

12.1 MIDDLE EAST AND AFRICA
- 12.1.1 SOUTH AFRICA
- 12.1.2 SAUDI ARABIA
- 12.1.3 U.A.E.
- 12.1.4 EGYPT
- 12.1.5 ISRAEL
- 12.1.6 REST OF MIDDLE EAST AND AFRICA

13 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 ASTRAZENECA
- 15.1.1 COMPANY SNAPSHOT
- 15.1.2 REVENUE ANALYSIS
- 15.1.3 COMPANY SHARE ANALYSIS
- 15.1.4 PRODUCT PORTFOLIO
- 15.1.5 RECENT DEVELOPMENT
15.2 PFIZER INC.
- 15.2.1 COMPANY SNAPSHOT
- 15.2.2 REVENUE ANALYSIS
- 15.2.3 COMPANY SHARE ANALYSIS
- 15.2.4 PRODUCT PORTFOLIO
- 15.2.5 RECENT DEVELOPMENTS
15.3 ABBOTT
- 15.3.1 COMPANY SNAPSHOT
- 15.3.2 REVENUE ANALYSIS
- 15.3.3 COMPANY SHARE ANALYSIS
- 15.3.4 PRODUCT PORTFOLIO
- 15.3.5 RECENT DEVELOPMENTS
15.4 NOVARTIS AG
- 15.4.1 COMPANY SNAPSHOT
- 15.4.2 REVENUE ANALYSIS
- 15.4.3 COMPANY SHARE ANALYSIS
- 15.4.4 PRODUCT PORTFOLIO
- 15.4.5 RECENT DEVELOPMENT
15.5 AM-PHARMA B.V.
- 15.5.1 COMPANY SNAPSHOT
- 15.5.2 COMPANY SHARE ANALYSIS
- 15.5.3 PRODUCT PORTFOLIO
- 15.5.4 RECENT DEVELOPMENT
15.6 BE BIOPHARMA
- 15.6.1 COMPANY SNAPSHOT
- 15.6.2 PRODUCT PORTFOLIO
- 15.6.3 RECENT DEVELOPMENT
15.7 PUREC.
- 15.7.1 COMPANY SNAPSHOT
- 15.7.2 PRODUCT PORTFOLIO
- 15.7.3 RECENT DEVELOPMENT
15.8 RALLYBIO
- 15.8.1 COMPANY SNAPSHOT
- 15.8.2 PRODUCT PORTFOLIO
- 15.8.3 RECENT DEVELOPMENTS
15.9 RAMPART BIOSCIENCE, INC.
- 15.9.1 COMPANY SNAPSHOT
- 15.9.2 PRODUCT PORTFOLIO
- 15.9.3 RECENT DEVELOPMENT
15.10 ROIVANT SCIENCES LTD.
- 15.10.1 COMPANY SNAPSHOT
- 15.10.2 PRODUCT PORTFOLIO
- 15.10.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

LIST OF TABLES

TABLE 1 VARIOUS ASPECTS OF HYPOPHOSPHATASIA (HPP)
TABLE 2 TARGETED TREATMENT OF HYPOPHOSPHATASIA
TABLE 3 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND)
TABLE 4 MIDDLE EAST AND AFRICA ODONTOPHOSPHATASIA IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 5 MIDDLE EAST AND AFRICA PSEUDOPHOSPHATASIA IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 6 MIDDLE EAST AND AFRICA OTHERS IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 7 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND)
TABLE 8 MIDDLE EAST AND AFRICA ENZYME REPLACEMENT THERAPY IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 9 MIDDLE EAST AND AFRICA SUPPORTIVE THERAPY IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 10 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND)
TABLE 11 MIDDLE EAST AND AFRICA INJECTABLE IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 12 MIDDLE EAST AND AFRICA ORAL IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 13 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 14 MIDDLE EAST AND AFRICA HOSPITAL PHARMACY IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 15 MIDDLE EAST AND AFRICA RETAIL PHARMACY IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 16 MIDDLE EAST AND AFRICA ONLINE PHARMACY IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 17 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY END-USER, 2022-2031 (USD THOUSAND)
TABLE 18 MIDDLE EAST AND AFRICA HOSPITALS IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 19 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN HYPOPHOSPHATASIA TREATMENTMARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 20 MIDDLE EAST AND AFRICA OTHERS IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 21 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND )
TABLE 22 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 23 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 24 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 25 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 26 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 27 SOUTH AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 28 SOUTH AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 29 SOUTH AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 30 SOUTH AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 31 SOUTH AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 32 SAUDI ARABIA HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 33 SAUDI ARABIA HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 34 SAUDI ARABIA HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 35 SAUDI ARABIA HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 36 SAUDI ARABIA HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 37 U.A.E. HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 38 U.A.E. HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 39 U.A.E. HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 40 U.A.E. HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 41 U.A.E. HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 42 EGYPT HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 43 EGYPT HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 44 EGYPT HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 45 EGYPT HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 46 EGYPT HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 47 ISRAEL HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 48 ISRAEL HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 49 ISRAEL HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 50 ISRAEL HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 51 ISRAEL HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 52 REST OF MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )

LIST OF FIGURES

FIGURE 1 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: SEGMENTATION
FIGURE 11 SEGMENTS COMPRISE THE MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPE
FIGURE 12 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET : EXECUTIVE SUMMARY
FIGURE 13 INCREASING DIAGNOSIS FOR HYPOPHOSPHATASIA IS DRIVING THE GROWTH OF THE MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET FROM 2024 TO 2031
FIGURE 14 THE TYPES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET IN 2024 AND 2031
FIGURE 15 DRIVERS, RESTRIANTS, OPPORTUNITIES, AND CHALLENGES OF HYPOPHOSPHATASIA TREATMENT MARKET
FIGURE 16 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY TYPES, 2023
FIGURE 17 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY TYPES, 2024-2031 (USD THOUSAND)
FIGURE 18 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY TYPES, CAGR (2024-2031)
FIGURE 19 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY TYPES, LIFELINE CURVE
FIGURE 20 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY THEREPY TYPE, 2023
FIGURE 21 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY THEREPY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 22 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY THEREPY TYPE, CAGR (2024-2031)
FIGURE 23 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY THEREPY TYPE, LIFELINE CURVE
FIGURE 24 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2023
FIGURE 25 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2024-2031 (USD THOUSAND)
FIGURE 26 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2024-2031)
FIGURE 27 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 28 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 29 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 30 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 31 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 32 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY END USER, 2023
FIGURE 33 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 34 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY END USER, CAGR (2024-2031)
FIGURE 35 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 36 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: SNAPSHOT (2023)
FIGURE 37 MIDDLE EAST AND AFRICA HYPOPHOSPHATASIA TREATMENT MARKET: COMPANY SHARE 2023 (%)